Targeting Notch in oncology: the path forward

S Majumder, JS Crabtree, TE Golde… - Nature Reviews Drug …, 2021 - nature.com
Notch signalling is involved in many aspects of cancer biology, including angiogenesis,
tumour immunity and the maintenance of cancer stem-like cells. In addition, Notch can …

Mutant p53 in colon cancer

M Nakayama, M Oshima - Journal of molecular cell biology, 2019 - academic.oup.com
The accumulation of genetic alterations in driver genes is responsible for the development
and malignant progression of colorectal cancer. Comprehensive genome analyses have …

Toward understanding cancer stem cell heterogeneity in the tumor microenvironment

F Bocci, L Gearhart-Serna, M Boareto… - Proceedings of the …, 2019 - National Acad Sciences
The epithelial–mesenchymal transition (EMT) and cancer stem cell (CSC) formation are two
paramount processes driving tumor progression, therapy resistance, and cancer metastasis …

lncRNA BREA2 promotes metastasis by disrupting the WWP2-mediated ubiquitination of Notch1

Z Zhang, Y Lu, F Liu, L Sang, C Shi… - Proceedings of the …, 2023 - National Acad Sciences
Notch has been implicated in human cancers and is a putative therapeutic target. However,
the regulation of Notch activation in the nucleus remains largely uncharacterized. Therefore …

Colorectal cancer stem cells: from the crypt to the clinic

A Zeuner, M Todaro, G Stassi, R De Maria - Cell stem cell, 2014 - cell.com
Since their first discovery, investigations of colorectal cancer stem cells (CSCs) have
revealed some unexpected properties, including a high degree of heterogeneity and …

[HTML][HTML] Common stemness regulators of embryonic and cancer stem cells

C Hadjimichael, K Chanoumidou… - World journal of stem …, 2015 - ncbi.nlm.nih.gov
Pluripotency of embryonic stem cells (ESCs) and induced pluripotent stem cells is regulated
by a well characterized gene transcription circuitry. The circuitry is assembled by ESC …

Drug resistance in non-small cell lung cancer: a potential for NOTCH targeting?

V Sosa Iglesias, L Giuranno, LJ Dubois, J Theys… - Frontiers in …, 2018 - frontiersin.org
Drug resistance is a major cause for therapeutic failure in non-small cell lung cancer
(NSCLC) leading to tumor recurrence and disease progression. Cell intrinsic mechanisms of …

Colon cancer therapy by focusing on colon cancer stem cells and their tumor microenvironment

Z Jahanafrooz, J Mosafer, M Akbari… - Journal of cellular …, 2020 - Wiley Online Library
Despite many advances and optimization in colon cancer treatment, tumor recurrence and
metastases make the development of new therapies necessary. Colon cancer stem cells …

[HTML][HTML] A microRNA miR-34a-regulated bimodal switch targets Notch in colon cancer stem cells

P Bu, KY Chen, JH Chen, L Wang, J Walters, YJ Shin… - Cell stem cell, 2013 - cell.com
Summary microRNAs regulate developmental cell-fate decisions, tissue homeostasis, and
oncogenesis in distinct ways relative to proteins. Here, we show that the tumor suppressor …

Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling

JP Sullivan, M Spinola, M Dodge, MG Raso, C Behrens… - Cancer research, 2010 - AACR
Aldehyde dehydrogenase (ALDH) is a candidate marker for lung cancer cells with stem cell-
like properties. Immunohistochemical staining of a large panel of primary non–small cell …